Ibuprofen inhibits the synaptic failure induced by the amyloid-β peptide in hippocampal neurons

Journal of Alzheimer's Disease

Volumn 35, Issue 3, 2013, Pages 463-473

  Zurita, Maria Paz ^a   Muñoz, Gonzalo ^a   Sepúlveda, Fernando J ^a   Gómez, Paulina ^a   Castillo, Carolina ^a   Burgos, Carlos F ^a   Fuentealba, Jorge ^a   Opazo, Carlos ^a,b   Aguayo, Luis G ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Alzheimer's disease; amyloid ; ibuprofen; neurotransmission; non steroidal anti inflammatory drugs

Indexed keywords

AMYLOID BETA PROTEIN; IBUPROFEN;

ALZHEIMER DISEASE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CALCIUM CELL LEVEL; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; NERVE CELL MEMBRANE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84880208332     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122314     Document Type: Article

References (40)

1. Reitz C, Brayne C (2011) Mayeux R Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
2. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
3. Demuro A, Parker I, Stutzmann GE (2010) Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 285, 12463-12468.
4. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112.
5. Butterfield SM, Lashuel HA (2010) Amyloidogenic proteinmembrane interactions: Mechanistic insight from model systems. Angew Chem Int Ed Engl 49, 5628-5654.
6. Sepulveda FJ, Parodi J, Peoples RW, Opazo C, Aguayo LG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820.
7. Aguayo LG, Parodi J, Sep'ulveda FJ, Opazo C (2009) Pore-forming neurotoxin-like mechanism for Aβ oligomerinduced synaptic failure. In Current Hypotheses and Research Milestones in Alzheimer's Disease. Springer, US, pp. 1-9.
8. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27, 741-749.
9. in 'tVeld BA, RuitenbergA, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MMB, Stricker BHC (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345, 1515-1521.
10. Zandi PP, Anthony JC, Hayden KM,Mehta K, Mayer L, Breitner JC (2002) Reduced incidence ofADwith NSAID but not H2 receptor antagonists: The Cache County Study. Neurology 59, 880-886.
11. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, MurphyMP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH (2001) A subset of NSAIDs lower amyloidogenic A[beta]42 independently of cyclooxygenase activity. Nature 414, 212-216.
12. Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE (2003) NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J Clin Invest 112, 440-449.
13. Agdeppa ED, Kepe V, Petri A, Satyamurthy N, Liu J, Huang SC, Small GW, Cole GM, Barrio JR (2003) In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer's brain using the positron emission tomography molecular imaging probe 2-(1-[6-[(2-[(18)F] fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene)malono nitrile. Neuroscience 117, 723-730.
14. Thomas T, Nadackal TG, Thomas K (2001) Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation. Neuroreport 12, 3263-3267.
15. Hirohata M, Ono K, Naiki H,YamadaM(2005) Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Neuropharmacology 49, 1088-1099.
16. Tapia JC, Mentis GZ, Navarrete R, Nualart F, Figueroa E, S'anchez A, Aguayo LG (2001) Early expression of glycine and GABAA receptors in developing spinal cord neurons. Effects on neurite outgrowth. Neuroscience 108, 493-506.
17. Yevenes GE, Peoples RW, Tapia JC, Parodi J, Soto X, Olate J, Aguayo LG (2003) Modulation of glycine-activated ion channel function by G-protein betagamma subunits. Nat Neurosci 6, 819-824.
18. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, Schubert D, Riek R (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A 102, 17342-17347.
19. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612.
20. Grosdidier A, Zoete V, Michielin O (2011) SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res 39, W270-W277.
21. Jang H, Zheng J, Lal R, Nussinov R (2008) New structures help the modeling of toxic amyloidbeta ion channels. Trends Biochem Sci 33, 91-100.
22. Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ (2008) Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci 28, 11950-11958.
23. Kim W, Hecht MH (2006) Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci U S A 103, 15824-15829.
24. Matsuzaki K (2007) Physicochemical interactions of amyloid beta-peptide with lipid bilayers. Biochim Biophys Acta 1768, 1935-1942.
25. Kandel ER, Schwartz JH, Jessell TH (2000) Principios de Neurociencia. Traducido por Agud, Jos'e L, MacGraw Hill, Madrid.
26. Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC, Aguayo LG (2010) β-Amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506-2514.
27. Domanska U, Pobudkowska A, Pelczarska A, Gierycz P (2009) pKa and solubility of drugs in water, ethanol, and 1-octanol. J Phys Chem B 113, 8941-8947.
28. Gasparini L, Rusconi L, Xu H, del Soldato P, Ongini E (2004) Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures. J Neurochem 88, 337-348.
29. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
30. Gandy S (2005) The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J Clin Invest 115, 1121-1129.
31. Selkoe DJ (2000) The origins of Alzheimer disease: A is for amyloid. JAMA 283, 1615-1617.
32. Lewis S (2012) Neurogenetics: Driving A- into reverse. Nat Rev Neurosci 13, 601.
33. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jonsson EG, Palotie A, BehrensTW,MagnussonOT,Kong A, Thorsteinsdottir U,Watts RJ, StefanssonK(2012)Amutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99.
34. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47, 425-432.
35. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G (2003) Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci 23, 7504-7509.
36. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, ColeGM(2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20, 5709-5714.
37. Hirohata M, Ono K, Yamada M (2008) Non-steroidal antiinflammatory drugs as anti-amyloidogenic compounds. Curr Pharm Des 14, 3280-3294.
38. Fu Q, Hue J, Li S (2007) Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci 27, 4154-4164.
39. Tomiyama T, Shoji A, Kataoka K, Suwa Y, Asano S, Kaneko H, Endo N (1996) Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J Biol Chem 271, 6839-6844.
40. Takeda T, Chang WE, Raman EP, Klimov DK (2010) Binding of nonsteroidal anti-inflammatory drugs to Abeta fibril. Proteins 78, 2849-2860.